Skip to content

13F-HR/A filed by RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR/A for the quarter ended 2023-09-30, filed 2023-11-15, with 1 holding row worth $37,587,910.

Accession
0001104659-23-118452
Filed
2023-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2023

A holdings report, amendment of type new holdings, 1 entries on the cover page, a total value of $37,587,910 stated on the cover page (in dollars after the unit check, H1), rows summing to $37,587,910 with VALUE read as dollars as filed, 13F file number 028-12884. Its rows are added to the quarter's base report (NEW HOLDINGS). The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CYTEK BIOSCIENCES INC23285D109COMMON STOCK6,809,404$37,587,910dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-23-118214 base2023-11-14acceptance time not in the bulk data set
13F-HR/A 0001104659-23-118452this filing2023-11-15acceptance time not in the bulk data set